US Equity
EDIT
— EDITAS MEDICINE, INC.Editas Medicine, Inc. is a clinical-stage genome editing company developing transformative medicines using CRISPR technology.
💰 Market cap: $449.68M📍 11 Hurley St, CAMBRIDGE, MA, 02141-2110 US🏷️ Biotechnology & Medical Research💵 Previous close: $2.60🔢 5,800 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $2.60 |
| 2026-07-23 | $2.73 |
| 2026-07-22 | $2.78 |
| 2026-07-21 | $2.89 |
| 2026-07-20 | $2.88 |
| 2026-07-17 | $2.98 |
| 2026-07-16 | $2.88 |
| 2026-07-15 | $3.04 |
| 2026-07-14 | $3.16 |
| 2026-07-13 | $3.16 |
| 2026-07-10 | $3.26 |
| 2026-07-09 | $3.30 |
| 2026-07-08 | $3.67 |
| 2026-07-07 | $3.75 |
| 2026-07-06 | $3.65 |
| 2026-07-02 | $3.65 |
| 2026-07-01 | $3.28 |
| 2026-06-30 | $3.24 |
| 2026-06-29 | $3.20 |
| 2026-06-26 | $2.85 |
| 2026-06-25 | $2.74 |
| 2026-06-24 | $2.80 |
| 2026-06-23 | $2.76 |
| 2026-06-22 | $2.80 |
| 2026-06-18 | $2.69 |
| 2026-06-17 | $2.55 |
| 2026-06-16 | $2.36 |
| 2026-06-15 | $2.46 |
| 2026-06-12 | $2.50 |
| 2026-06-11 | $2.44 |
| 2026-06-10 | $2.48 |
| 2026-06-09 | $2.65 |
| 2026-06-08 | $2.65 |
| 2026-06-05 | $2.71 |
| 2026-06-04 | $2.99 |
| 2026-06-03 | $2.78 |
| 2026-06-02 | $2.82 |
| 2026-06-01 | $3.34 |
| 2026-05-29 | $3.46 |
| 2026-05-28 | $3.43 |
| 2026-05-27 | $3.57 |
| 2026-05-26 | $3.08 |
| 2026-05-22 | $2.76 |
| 2026-05-21 | $2.67 |
| 2026-05-20 | $2.60 |
| 2026-05-19 | $2.46 |
| 2026-05-18 | $2.53 |
| 2026-05-15 | $2.62 |
| 2026-05-14 | $2.85 |
| 2026-05-13 | $2.90 |
| 2026-05-12 | $2.93 |
| 2026-05-11 | $3.06 |
| 2026-05-08 | $3.11 |
| 2026-05-07 | $3.03 |
| 2026-05-06 | $3.17 |
| 2026-05-05 | $3.04 |
| 2026-05-04 | $3.00 |
| 2026-05-01 | $2.90 |
| 2026-04-30 | $3.00 |
| 2026-04-29 | $2.82 |
| 2026-04-28 | $3.06 |